Picture of Amplia Therapeutics logo

ATX Amplia Therapeutics Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Amplia Therapeutics, fiscal year end - March 31st, AUD millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital-0.549-0.954-1.07-1.35-0.968
Other Operating Cash Flow
Cash from Operating Activities-2.92-4.4-5.29-5.13-6.89
Capital Expenditures-0.005-0.014-0.018-0.002-0.002
Purchase of Fixed Assets
Other Investing Cash Flow Items0-0.012-0.0410
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-0.005-0.027-0.058-0.002-0.002
Financing Cash Flow Items-0.4-1.18-0.041-0.693-2.88
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities3.6617.2-0.084-0.77314.3
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.7412.8-5.35-5.877.48